A Study of Two Formulations of Ixekizumab in Healthy Participants

NCT04259346 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

245

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Ixekizumab

Sponsor

Eli Lilly and Company